Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-021396·Akari Therapeutics Plc
Schedule 13G ownership disclosure
AKARI THERAPEUTICS PLC
Ordinary Shares, $0.0001 par value · CUSIP: 00972G207
Event date: 2024-11-14
- Filing-level shares
- 8,294,508,000
- Percent of class
- 15.5%
- Hoyoung Huh, M.D., Ph.D.
Shares: 8,294,508,000 · Class: 15.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021396
- Form type
- SCHEDULE 13G
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Feb 14, 2025
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13G beneficial ownership